News

Published on 11 Jan 2022 on Benzinga

60 Biggest Movers From Yesterday

Article preview image

 

Check out these big penny stock gainers and losers

Read the rest of the article
NASDAQ.LHDX price evolution
NASDAQ.ADMP price evolution
NASDAQ.ARCE price evolution
NASDAQ.PXLW price evolution
NYSE.MYE price evolution
NASDAQ.NRIX price evolution
NYSE.NVS price evolution
NASDAQ.FOLD price evolution
NYSE.STEM price evolution
NASDAQ.BCRX price evolution
NASDAQ.CDNA price evolution
NASDAQ.JAZZ price evolution
SIX.NOVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly...

There's a common problem with passive income: Generating it isn't as passive as investors expect....

Motley Fool via Yahoo Finance 14 Apr 2024
Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate

Novartis NVS entered into an exclusive strategic license agreement with a clinical-stage biotechn...

Zacks via Yahoo Finance 12 Apr 2024
Novartis (NVS) to Undertake Job Cuts in Development Department

Novartis NVS is set to reduce its workforce by 680, per a report by Reuters. It will do so in its...

Zacks via Yahoo Finance 11 Apr 2024
MorphoSys recommends shareholders to accept Novartis takeover offer By Investing.com

MorphoSys AG (FSE: MOR; NASDAQ: MOR) has recommended its shareholders to accept a takeover offer...

Investing.com 11 Apr 2024
Novartis commences tender offer for MorphoSys (NYSE:NVS)

Novartis has commenced its tender offer to acquire MorphoSys for €2.7B, offering a premium of 142...

Seeking Alpha 11 Apr 2024
Weekly Upgrades and Downgrades

During these busy times, it pays to stay on top of the latest profit opportunities. And today’s b...

InvestorPlace via Yahoo Finance 8 Apr 2024
Why Is Novartis Stock Trading Higher On Thursday? - Novartis (NYSE:NVS)

Thursday, Novartis AG NVS shares are trading higher after the company confirmed plans to file for...

Benzinga 4 Apr 2024
Biotech Roundtable: Who will bring the next CRISPR drug to market? (NASDAQ:CRSP)

CRISPR gene editing technology has been heralded as a revolutionary breakthrough in drug...

Seeking Alpha 2 Apr 2024
Carisma Therapeutics appoints new board member

Carisma Therapeutics Inc. ( NASDAQ : CARM), a biopharmaceutical company engaged in the developmen...

Investing.com 1 Apr 2024
11 Oversold Blue Chip Stocks to Buy Right Now

In this article, we will take a look at the 11 oversold blue chip stocks to buy right now. To ski...

Insider Monkey via Yahoo Finance 30 Mar 2024

Copyright Statfolio @ 2024

Social Accounts